Jung‐Jyh Hung

1.3k total citations
38 papers, 1.0k citations indexed

About

Jung‐Jyh Hung is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jung‐Jyh Hung has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 9 papers in Surgery. Recurrent topics in Jung‐Jyh Hung's work include Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (16 papers) and Lung Cancer Research Studies (9 papers). Jung‐Jyh Hung is often cited by papers focused on Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (16 papers) and Lung Cancer Research Studies (9 papers). Jung‐Jyh Hung collaborates with scholars based in Taiwan and United States. Jung‐Jyh Hung's co-authors include Wen‐Hu Hsu, Yu–Chung Wu, Teh‐Ying Chou, Wen-Juei Jeng, Yi‐Chen Yeh, Biing-Shiun Huang, Kou-Juey Wu, Teh‐Ying Chou, Kou‐Juey Wu and Wen‐Juei Jeng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Jung‐Jyh Hung

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung‐Jyh Hung Taiwan 17 790 310 223 197 114 38 1.0k
Kenta Tane Japan 13 633 0.8× 383 1.2× 214 1.0× 101 0.5× 76 0.7× 64 883
Hao‐Xian Yang China 17 675 0.9× 219 0.7× 106 0.5× 133 0.7× 46 0.4× 51 937
Mercedes Canela Spain 9 1.1k 1.4× 545 1.8× 135 0.6× 128 0.6× 90 0.8× 17 1.2k
Dori Giroux United States 8 420 0.5× 171 0.6× 150 0.7× 118 0.6× 78 0.7× 9 618
Seiichi Kakegawa Japan 17 567 0.7× 372 1.2× 75 0.3× 219 1.1× 211 1.9× 52 915
Qingsong Pang China 17 449 0.6× 416 1.3× 124 0.6× 188 1.0× 87 0.8× 87 867
Jumpei Kashima Japan 13 311 0.4× 233 0.8× 114 0.5× 78 0.4× 53 0.5× 41 566
P. Jacoulet France 13 481 0.6× 577 1.9× 32 0.1× 147 0.7× 33 0.3× 53 823
Guang Li China 16 384 0.5× 406 1.3× 149 0.7× 107 0.5× 96 0.8× 60 770
Jinli Ma China 17 400 0.5× 211 0.7× 328 1.5× 128 0.6× 235 2.1× 55 913

Countries citing papers authored by Jung‐Jyh Hung

Since Specialization
Citations

This map shows the geographic impact of Jung‐Jyh Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Jyh Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Jyh Hung more than expected).

Fields of papers citing papers by Jung‐Jyh Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Jyh Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Jyh Hung. The network helps show where Jung‐Jyh Hung may publish in the future.

Co-authorship network of co-authors of Jung‐Jyh Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Jyh Hung. A scholar is included among the top collaborators of Jung‐Jyh Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Jyh Hung. Jung‐Jyh Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Sheng‐Wei, Jung‐Jyh Hung, Po‐Kuei Hsu, et al.. (2024). Promoter methylation and increased expression of PD-L1 in patients with active tuberculosis. Microbial Cell. 11. 278–278. 1 indexed citations
3.
Hsu, Po‐Kuei, et al.. (2022). Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy. BMC Cancer. 22(1). 637–637. 6 indexed citations
4.
Chen, Chun-Ku, Po‐Kuei Hsu, Jung‐Jyh Hung, et al.. (2019). Electromagnetic navigation-guided versus computed tomography-guided percutaneous localization of small lung nodules before uniportal video-assisted thoracoscopic surgery: a propensity score-matched analysis. European Journal of Cardio-Thoracic Surgery. 58(Supplement_1). i85–i91. 10 indexed citations
5.
Wu, Yu–Chung, Jung‐Jyh Hung, Yi‐Chen Yeh, et al.. (2017). Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection. Oncotarget. 8(45). 79712–79721. 1 indexed citations
6.
Hung, Jung‐Jyh, Yi‐Chen Yeh, Wen-Juei Jeng, et al.. (2015). Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. Journal of Thoracic Oncology. 10(9). 1328–1336. 34 indexed citations
7.
Chen, Hsiao‐Fan, Chi-Hung Huang, Chung‐Ji Liu, et al.. (2014). Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. Nature Communications. 5(1). 4697–4697. 65 indexed citations
8.
9.
Hung, Jung‐Jyh, Po‐Kuei Hsu, Chien‐Sheng Huang, et al.. (2013). Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: A review of 5 years' experience. Journal of the Chinese Medical Association. 76(12). 693–697. 16 indexed citations
10.
Hung, Jung‐Jyh, Wen-Juei Jeng, Wen‐Hu Hsu, et al.. (2012). Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. CHEST Journal. 142(1). 141–150. 34 indexed citations
11.
Hung, Jung‐Jyh, et al.. (2012). Clinical significance of E2F1 protein expression in non-small cell lung cancer. Experimental Hematology and Oncology. 1(1). 18–18. 17 indexed citations
12.
Hung, Jung‐Jyh, Wen-Juei Jeng, Wen‐Hu Hsu, et al.. (2012). Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(7). 1115–1123. 96 indexed citations
13.
Yeh, Yi‐Chen, Jung‐Jyh Hung, Teh‐Ying Chou, et al.. (2011). Overexpression of TLAK cell‐originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. Cancer Science. 103(4). 731–738. 38 indexed citations
14.
Wang, Bing-Yen, Yu–Chung Wu, Jung‐Jyh Hung, et al.. (2011). Prognosis of Non-Small-Cell Lung Cancer with Unexpected Pleural Spread at Thoracotomy. Journal of Surgical Research. 169(1). e1–e5. 11 indexed citations
15.
Hung, Jung‐Jyh, Wen-Juei Jeng, Wen‐Hu Hsu, Biing-Shiun Huang, & Yu–Chung Wu. (2011). Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 7(2). 397–405. 22 indexed citations
16.
Wang, Bing-Yen, Jung‐Jyh Hung, Wen-Juei Jeng, et al.. (2010). Surgical Outcomes in Resected Non-small Cell Lung Cancer ≤ 1 cm in Diameter. Journal of the Chinese Medical Association. 73(6). 308–313. 3 indexed citations
17.
Hung, Jung‐Jyh, Chih‐Cheng Hsieh, Shih‐Chieh Lin, & Liang-Shun Wang. (2009). Squamous Cell Carcinoma in a Large Epiphrenic Esophageal Diverticulum. Digestive Diseases and Sciences. 54(6). 1365–1368. 6 indexed citations
18.
Hung, Jung‐Jyh, et al.. (2008). Esophageal Carcinosarcoma With Basaloid Squamous Cell Carcinoma and Osteosarcoma. The Annals of Thoracic Surgery. 85(3). 1102–1104. 11 indexed citations
19.
Hung, Jung‐Jyh, et al.. (2008). Primary Synovial Sarcoma of the Posterior Chest Wall. The Annals of Thoracic Surgery. 85(6). 2120–2122. 14 indexed citations
20.
Hung, Jung‐Jyh, et al.. (2006). Major hemorrhage and subsequent cardiac tamponade during mediastinoscopy. Journal of Thoracic and Cardiovascular Surgery. 133(1). 269–270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026